|
⚲
|
| Keyboard |
| Shalwitz Robert
✚
|
|
|---|---|
| CIK # | 0001602395 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001602395] | |
| 4 | [0001602395] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Shalwitz Robert | |
| Akebia Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to Buy) · derivative
|
2014-05-14 | Grant | 21,667 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2014-03-25 | Conversion | 12,560 | ||
|
Akebia Therapeutics Inc AKBA
Series A Convertible Preferred Stock · derivative
|
2014-03-25 | Conversion | 850 | ||
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2014-03-25 | Conversion | 17,016 | ||
|
Akebia Therapeutics Inc AKBA
Series C Convertible Preferred Stock · derivative
|
2014-03-25 | Conversion | 2,500 | ||
|
Akebia Therapeutics Inc AKBA
Series A Convertible Preferred Stock · derivative
|
2014-03-25 | Conversion | 3,403 | ||
|
Akebia Therapeutics Inc AKBA
Series B Convertible Preferred Stock · derivative
|
2014-03-25 | Conversion | 2,070 |